Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06549153 · ClinicalTrials.gov registry record · NA

ACT-Together (Acting on Cancer Testing-Together)

A NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06549153: Active NA study of Cancer, sponsored by M.D. Anderson Cancer Center.

NCT06549153 is a NA study of Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06549153, a NA study of Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.

Conditions Studied

Interventions

  • OTHER Focus Group
  • OTHER Education Content

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-12-18
Est. Completion 2027-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06549153

The ClinicalTrials.gov registry entry for NCT06549153 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Focus Group is the first listed.

NCT06549153 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06549153 about?

NCT06549153 is a clinical study titled "ACT-Together (Acting on Cancer Testing-Together)". To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.

What is the current status of trial NCT06549153?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-18. Estimated completion is 2027-12-31.

What conditions does trial NCT06549153 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06549153?

The interventions under investigation include: Focus Group (OTHER), Education Content (OTHER).

Who is sponsoring clinical trial NCT06549153?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06549153 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.